Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

Maravai Lifesciences Holdings (MRVI) Other Gross PP&E Adjustments (2020 - 2025)

Maravai Lifesciences Holdings has reported Other Gross PP&E Adjustments over the past 6 years, most recently at $11.3 million for Q4 2025.

  • Quarterly results put Other Gross PP&E Adjustments at $11.3 million for Q4 2025, up 126.17% from a year ago — trailing twelve months through Dec 2025 was $11.3 million (up 126.17% YoY), and the annual figure for FY2025 was $11.3 million, up 126.17%.
  • Other Gross PP&E Adjustments for Q4 2025 was $11.3 million at Maravai Lifesciences Holdings, up from -$7.2 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for MRVI hit a ceiling of $11.3 million in Q4 2025 and a floor of -$94.3 million in Q2 2023.
  • Median Other Gross PP&E Adjustments over the past 5 years was -$19.8 million (2021), compared with a mean of -$31.8 million.
  • Biggest five-year swings in Other Gross PP&E Adjustments: tumbled 1551.72% in 2022 and later skyrocketed 126.17% in 2025.
  • Maravai Lifesciences Holdings' Other Gross PP&E Adjustments stood at -$20.9 million in 2021, then crashed by 210.53% to -$65.0 million in 2022, then surged by 50.63% to -$32.1 million in 2023, then plummeted by 34.79% to -$43.2 million in 2024, then surged by 126.17% to $11.3 million in 2025.
  • The last three reported values for Other Gross PP&E Adjustments were $11.3 million (Q4 2025), -$7.2 million (Q3 2025), and -$14.4 million (Q2 2025) per Business Quant data.